In the past research, CD4+ and CD8+ T cells have been well documented to play important roles in antitumor immune responses and as clinically useful prognostic markers in colon cancer [33–35], dendritic cells can present tumor antigens and activate the naive T cells [36], and the increase of plasma cells indicates an obvious humoral immune response [37]. The gene discussed is CD4; the disease is neoplasm.